Charli Dominguez

1.3k total citations
11 papers, 981 citations indexed

About

Charli Dominguez is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Charli Dominguez has authored 11 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Charli Dominguez's work include Cancer Cells and Metastasis (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immune cells in cancer (3 papers). Charli Dominguez is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immune cells in cancer (3 papers). Charli Dominguez collaborates with scholars based in United States, India and Germany. Charli Dominguez's co-authors include Claudia Palena, Justin M. David, Duane H. Hamilton, Kristen K. McCampbell, James L. Gulley, Jeffrey Schlom, Desiree H. Floyd, Benjamin Purow, Benjamin Kefas and Kwong-Yok Tsang and has published in prestigious journals such as Pharmacology & Therapeutics, Cancer Discovery and Seminars in Cancer Biology.

In The Last Decade

Charli Dominguez

11 papers receiving 974 citations

Peers

Charli Dominguez
Xiubao Ren China
Yuko Hosoe Japan
Sugandha Saxena United States
Sofia Sousa France
Gali Soria Israel
Guohui Qin China
Jenean O’Brien United States
Yueyun Pan China
Yinda Yu Sweden
Qingxiang Zeng China
Xiubao Ren China
Charli Dominguez
Citations per year, relative to Charli Dominguez Charli Dominguez (= 1×) peers Xiubao Ren

Countries citing papers authored by Charli Dominguez

Since Specialization
Citations

This map shows the geographic impact of Charli Dominguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charli Dominguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charli Dominguez more than expected).

Fields of papers citing papers by Charli Dominguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charli Dominguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charli Dominguez. The network helps show where Charli Dominguez may publish in the future.

Co-authorship network of co-authors of Charli Dominguez

This figure shows the co-authorship network connecting the top 25 collaborators of Charli Dominguez. A scholar is included among the top collaborators of Charli Dominguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charli Dominguez. Charli Dominguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Dominguez, Charli, Justin M. David, & Claudia Palena. (2017). Epithelial-mesenchymal transition and inflammation at the site of the primary tumor. Seminars in Cancer Biology. 47. 177–184. 119 indexed citations
2.
Hamilton, Duane H., Justin M. David, Charli Dominguez, & Claudia Palena. (2017). Development of Cancer Vaccines Targeting Brachyury, a Transcription Factor Associated with Tumor Epithelial-Mesenchymal Transition. Cells Tissues Organs. 203(2). 128–138. 17 indexed citations
3.
Dominguez, Charli, Kristen K. McCampbell, Justin M. David, & Claudia Palena. (2017). Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer. JCI Insight. 2(21). 129 indexed citations
4.
David, Justin M., Charli Dominguez, Kristen K. McCampbell, et al.. (2017). A novel bifunctional anti-PD-L1/TGF-β Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells. OncoImmunology. 6(10). e1349589–e1349589. 151 indexed citations
5.
Dominguez, Charli, Kwong-Yok Tsang, & Claudia Palena. (2016). Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies. Cell Death and Disease. 7(9). e2380–e2380. 38 indexed citations
6.
David, Justin M., Charli Dominguez, & Claudia Palena. (2016). Pharmacological and immunological targeting of tumor mesenchymalization. Pharmacology & Therapeutics. 170. 212–225. 14 indexed citations
7.
Fernando, Romaine I., Duane H. Hamilton, Charli Dominguez, et al.. (2016). IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib. Oncotarget. 7(27). 42031–42044. 51 indexed citations
8.
David, Justin M., Charli Dominguez, Duane H. Hamilton, & Claudia Palena. (2016). The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance. Vaccines. 4(3). 22–22. 307 indexed citations
9.
Kefas, Benjamin, Desiree H. Floyd, Laurey Comeau, et al.. (2013). A miR-297/hypoxia/DGK-α axis regulating glioblastoma survival. Neuro-Oncology. 15(12). 1652–1663. 39 indexed citations
10.
Dominguez, Charli, Desiree H. Floyd, Aizhen Xiao, et al.. (2013). Diacylglycerol Kinase α Is a Critical Signaling Node and Novel Therapeutic Target in Glioblastoma and Other Cancers. Cancer Discovery. 3(7). 782–797. 90 indexed citations
11.
Floyd, Desiree H., Benjamin Kefas, Oleksandr Seleverstov, et al.. (2012). Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch. Neuro-Oncology. 14(10). 1215–1226. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiubao Ren Breakdown of academic impact, for papers by Yuko Hosoe Breakdown of academic impact, for papers by Sugandha Saxena Breakdown of academic impact, for papers by Sofia Sousa Breakdown of academic impact, for papers by Gali Soria Breakdown of academic impact, for papers by Guohui Qin Breakdown of academic impact, for papers by Jenean O’Brien Breakdown of academic impact, for papers by Yueyun Pan Breakdown of academic impact, for papers by Yinda Yu Breakdown of academic impact, for papers by Qingxiang Zeng
Rankless by CCL
2026